Publications by authors named "Suchitra Hourigan"

Background: Bariatric surgery is highly effective in achieving weight loss in children and adolescents with severe obesity, however the underlying mechanisms are incompletely understood, and gut microbiome changes are unknown.

Objectives: 1) To comprehensively examine gut microbiome and metabolome changes after laparoscopic vertical sleeve gastrectomy (VSG) in adolescents and 2) to assess whether the microbiome/metabolome changes observed with VSG influence phenotype using germ-free murine models.

Design: 1) A longitudinal observational study in adolescents undergoing VSG with serial stool samples undergoing shotgun metagenomic microbiome sequencing and metabolomics (polar metabolites, bile acids and short chain fatty acids) and 2) a human-to-mouse fecal transplant study.

View Article and Find Full Text PDF

Exposing C-section infants to the maternal vaginal microbiome, coined "vaginal seeding", partially restores microbial colonization. However, whether vaginal seeding decreases metabolic disease risk is unknown. Therefore, we assessed the effect of vaginal seeding of human infants on adiposity in a murine model.

View Article and Find Full Text PDF

Background: Cesarean section delivery is associated with altered early-life bacterial colonization and later adverse inflammatory and immune health outcomes. Although gut bacteriophages can alter gut microbiome composition and impact host immune responses, little is known about how delivery mode impacts bacteriophage colonization over time. To begin to address this we examined how delivery mode affected bacteriophage colonization over the first two years of life.

View Article and Find Full Text PDF

Background: While the microbiome is increasingly seen as a targetable contributor to atopic dermatitis (AD), questions remain as to whether the dysbiosis is secondary to diseased skin or if it predates symptom onset. Previous work has evaluated how the skin microbiome changes with age and established the influence of factors like delivery mode and breastfeeding on global microbiome diversity. However, these studies were unable to identify taxa which predict subsequent AD.

View Article and Find Full Text PDF

There has been an increase in the prevalence of Clostridioides difficile (C. diff) causing significant economic impact on the health care system. Although toxigenic C.

View Article and Find Full Text PDF
Article Synopsis
  • Elective, prelabor C-sections limit newborn exposure to beneficial vaginal microbiota, potentially leading to differences in microbiota development and increased risks of immune and metabolic diseases.
  • A clinical trial compared vaginal seeding (applying maternal vaginal fluids to C-section newborns) against a placebo to see its effects on the microbiota in neonates.
  • Results showed that vaginal seeding improved transfer of maternal microbes and changed the composition of skin and stool microbiota, highlighting the need for further research to explore its long-term impacts.
View Article and Find Full Text PDF

Background And Aims: Faecal microbiota transplant [FMT] is effective in treating recurrent Clostridioides difficile infection [CDI] and restores gut microbiota composition. This is unlikely to account for its entire mechanism of efficacy, as studies have shown that factors such as bile acids influence the risk of infection by affecting Clostridioides difficile germination. We therefore aimed to investigate longitudinal changes in the gut bile acid composition after FMT performed for recurrent CDI, in children with and without inflammatory bowel disease [IBD].

View Article and Find Full Text PDF

Early-life microbial colonization plays a key role in future health. In this issue of Cell Host & Microbe, Bogaert et al. unravel the complexities of mother-infant microbial seeding by examining multiple maternal and infant niches.

View Article and Find Full Text PDF
Article Synopsis
  • The gut microbiome is essential for health, and its imbalance (dysbiosis) can affect disease severity, particularly in adults with COVID-19.
  • In children, the gut microbiome is still developing, and there's less research on its impact during COVID-19, though dysbiosis has been observed in pediatric cases.
  • The review explores differences in gut microbiome changes between children and adults with COVID-19 and suggests possible mechanisms and therapeutic approaches involving the microbiome.
View Article and Find Full Text PDF
Article Synopsis
  • Maternal-child microbial seeding interventions aim to expose infants delivered via C-section to their mother's microbiome, which they miss out on during the surgery.
  • These interventions are thought to help restore the infant's microbiome and support normal immune development, potentially decreasing inflammatory issues linked to C-sections.
  • The text reviews the reasoning behind these interventions, the scientific evidence supporting them, and the ongoing debates and controversies related to their use.
View Article and Find Full Text PDF

Background: Parenteral nutrition-associated cholestasis (PNAC) in the neonatal intensive care unit (NICU) causes significant morbidity and associated healthcare costs. Laboratory detection of PNAC currently relies on elevated serum conjugated bilirubin levels in the aftermath of impaired bile flow. Here, we sought to identify fecal biomarkers, which when integrated with clinical data, would better predict risk for developing PNAC.

View Article and Find Full Text PDF
Article Synopsis
  • Understanding maternal parenting confidence is crucial for improving breastfeeding initiation and duration, but its impact has not been extensively studied.
  • In a study of 1,023 mother-infant pairs, researchers found a negative association between breastmilk feeding frequency at 6 months and maternal confidence scores, but this link disappeared when accounting for ethnicity.
  • No significant relationship was found between breastmilk feeding frequency and maternal confidence at 12 months, highlighting the need for more research on factors that can enhance breastfeeding rates.
View Article and Find Full Text PDF

Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhea and has high rates of recurrent disease. As a disease associated with intestinal dysbiosis, gastrointestinal microbiome manipulation and fecal microbiota transplantation (FMT) have evolved as effective, although relatively unregulated therapeutics and not without safety concerns. FMT for the treatment of CDI has been well studied in adults with increasing data reported in children.

View Article and Find Full Text PDF

Background: Children with inflammatory bowel disease [IBD] are disproportionally affected by recurrent Clostridioides difficile infection [rCDI]. Although faecal microbiota transplantation [FMT] has been used with good efficacy in adults with IBD, little is known about outcomes associated with FMT in paediatric IBD.

Methods: We performed a retrospective review of FMT at 20 paediatric centres in the USA from March 2012 to March 2020.

View Article and Find Full Text PDF

Background: Pediatric SARS-CoV-2 data remain limited and seropositivity rates in children were reported as <1% early in the pandemic. Seroepidemiologic evaluation of SARS-CoV-2 in children in a major metropolitan region of the US was performed.

Methods: Children and adolescents ≤19 years were enrolled in a cross-sectional, observational study of SARS-CoV-2 seroprevalence from July-October 2020 in Northern Virginia, US.

View Article and Find Full Text PDF

Fecal microbiota transplantation (FMT) is currently the most effective but loosely regulated therapy, for recurrent Clostridioides difficile infection (rCDI) in pediatrics. Over the last 2 years, there have been mounting challenges in the ability to provide FMT to pediatric patients. Firstly, an Food and Drug Administration (FDA) safety alert in 2019 reported transmission of a multidrug resistant organism from FMT donor to recipient resulting in the death of 1 patient.

View Article and Find Full Text PDF
Article Synopsis
  • The impact of the 2019 FDA safety alert about multidrug resistant organisms and the COVID-19 pandemic on pediatric fecal microbiota transplantation (FMT) is not well understood.
  • A survey of pediatric gastroenterologists revealed that a significant number altered their FMT practices due to these events, with 47% responding to the FDA alert and 83% to the pandemic, resulting in 61% of programs being stopped.
  • Overall, these factors have greatly affected the access and availability of FMT for children.
View Article and Find Full Text PDF

Objectives: To determine if maternal confidence affects emergency department (ED) utilization in the first year of life.

Methods: This retrospective cohort study examined the Maternal Confidence Questionnaire responses from a longitudinal birth cohort study and ED visits for these subjects across all Inova hospitals from January 2012 to July 2017 for full-term children 12 months or younger at the time of visit. Using logistic regression, maternal confidence, maternal race/ethnicity, age, education, parity, and insurance were evaluated against Emergency Severity Index acuity levels and ED visit frequency.

View Article and Find Full Text PDF

Background: Stool metabolites provide essential insights into the function of the gut microbiome. The current gold standard for storage of stool samples for metabolomics is flash-freezing at - 80 °C which can be inconvenient and expensive. Ambient temperature storage of stool is more practical, however no available methodologies adequately preserve the metabolomic profile of stool.

View Article and Find Full Text PDF